A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors
Autor: | Giaccone G, Cj, Punt, Yukio Ando, Ruijter R, Nishi N, Peters M, Bm, Blomberg, Rj, Scheper, Hj, Vliet, Aj, Den Eertwegh, Roelvink M, Beijnen J, Hm, Pinedo |
---|---|
Zdroj: | Europe PubMed Central |
Databáze: | OpenAIRE |
Externí odkaz: |